Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review - Top-Institutions - MDSpire

Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review

  • By

  • Logan R. Van Nynatten

  • Diyaa Bokhary

  • Michelle Yee Suet Wong

  • Jocelyn Wang

  • Henri Fero

  • Christopher McChesney

  • Kyle Fiorini

  • Leann Blake

  • Douglas D. Fraser

  • Marat Slessarev

  • Aleksandra Leligdowicz

  • Bram Rochwerg

  • John Basmaji

  • November 27, 2025

  • 0 min

Share

Top Institutions in Emergency Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Genomics

  • #2

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Systems Biology
    • Clinical Trials

  • #3

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Translational Research
    • Biomarker Discovery

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Immunogenomics
    • Clinical Trial Design

  • #5

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Critical Care Medicine
    • Genomics
    • Systems Immunology

Original Source(s)

Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review

  • by Logan R. Van Nynatten, Diyaa Bokhary, Michelle Yee Suet Wong, Jocelyn Wang, Henri Fero, Christopher McChesney, Kyle Fiorini, Leann Blake, Douglas D. Fraser, Marat Slessarev, Aleksandra Leligdowicz, Bram Rochwerg, John Basmaji

  • November 27, 2025

Related Content

Development Process of a Clinical Decision Support System for Empiric Antibiotic Therapies in Patients With Sepsis: Case Study

Exploratory Study of Bioactive Adrenomedullin as a Potential Biomarker for Severe Infections in Emergency Department Patients

Measuring signatures of host resistance, disease tolerance, and damage in human sepsis: a prospective cohort study